Leskovsek Natasha is an experienced regulatory and clinical development advisor, specializing in the pharmaceutical, biotechnology, medical device, and food dietary supplement industries. She provides practical compliance solutions at the intersection of science and regulation, offering expertise on US Food and Drug Administration regulatory matters and conducting regulatory diligence for entities investing in FDA-regulated companies.
Leskovsek Natasha has worked with various clients in the life sciences sector, including RayzeBio and Gracell Biotechnologies, providing guidance on mergers and acquisitions, corporate partnering, licensing, and regulatory compliance. Her extensive experience and knowledge make her a valuable asset in navigating the complex landscape of FDA regulations and clinical development in the healthcare industry.
Generated from the website